Sales 2024 * | 120M 164M | Sales 2025 * | 130M 178M | Capitalization | 99.88M 136M |
---|---|---|---|---|---|
Net income 2024 * | -16M -21.84M | Net income 2025 * | 1M 1.36M | EV / Sales 2024 * | 0.83 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
-6.18
x | P/E ratio 2025 * |
210
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.77% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 19-01-31 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 19-06-30 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 03-10-31 |
James Tyree
BRD | Director/Board Member | 71 | 16-09-30 |
William McKee
BRD | Director/Board Member | 62 | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |